Last reviewed · How we verify
Aristospan (TRIAMCINOLONE HEXACETONIDE)
Aristospan (generic name: TRIAMCINOLONE HEXACETONIDE) is a Corticosteroid Small molecule drug developed by Ethypharm. It is currently FDA-approved (first approved 1969) for Alopecia areata, Discoid lupus erythematosus, Keloid scar.
Aristospan (Triamcinolone Hexacetonide) is a corticosteroid medication that targets the glucocorticoid receptor. It is used to treat various skin conditions, including alopecia areata, discoid lupus erythematosus, and keloid scars. Originally developed by Sandoz, it is now owned by Ethypharm and has been FDA-approved since 1969. As an off-patent medication, it is available from various manufacturers. Key safety considerations include potential side effects such as skin thinning and increased risk of infections.
At a glance
| Generic name | TRIAMCINOLONE HEXACETONIDE |
|---|---|
| Sponsor | Ethypharm |
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 1969 |
Approved indications
- Alopecia areata
- Discoid lupus erythematosus
- Keloid scar
- Lichen planus
- Lichen simplex chronicus
- Necrobiosis lipoidica diabeticorum
Common side effects
Key clinical trials
- A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome (PHASE4)
- Dose Dependent Steroid Injections (PHASE4)
- Local Methotrexate Injections for the Treatment of Nail Psoriasis (PHASE4)
- Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone (PHASE4)
- Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia (NA)
- USG-Guided Shoulder Injections in Frozen Shoulder (NA)
- Bladder Directed vs. Pelvic Floor Therapy in IC/BPS (PHASE2)
- Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aristospan CI brief — competitive landscape report
- Aristospan updates RSS · CI watch RSS
- Ethypharm portfolio CI
Frequently asked questions about Aristospan
What is Aristospan?
What is Aristospan used for?
Who makes Aristospan?
What is the generic name of Aristospan?
What drug class is Aristospan in?
When was Aristospan approved?
What development phase is Aristospan in?
What does Aristospan target?
Related
- Drug class: All Corticosteroid drugs
- Target: All drugs targeting Glucocorticoid receptor
- Manufacturer: Ethypharm — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Alopecia areata
- Indication: Drugs for Discoid lupus erythematosus
- Indication: Drugs for Keloid scar
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing